Medicare Enrolled

Dr. Robert Schreiman, MD

Family Medicine · Tustin, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
1101 BRYAN AVE, Tustin, CA 92780
7143525800
In practice since 2006 (19 years)
NPI: 1871605196 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Schreiman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Schreiman? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Schreiman

Dr. Robert Schreiman is a family medicine specialist in Tustin, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Schreiman performed 1,915 Medicare services across 697 unique beneficiaries.

Between the years covered by Open Payments, Dr. Schreiman received a total of $5,575 from 43 pharmaceutical and/or device companies across 196 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Schreiman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 11% volume in CA $5,575 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,915
Medicare services
Top 11% in CA for family medicine
697
Unique beneficiaries
$92
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~101 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Home visit, established patient, moderate complexity
A home visit for an established patient involving moderate medical decision making. The visit requires at least 40 minutes of time if time is used to determine the level of service.
980 $103 $171
Nursing facility visit, low complexity
A daily follow-up visit for an existing patient in a nursing facility involving straightforward medical decision making. The visit requires at least 15 minutes of time if time is used to determine the level of care.
270 $58 $92
Home visit, established patient, low complexity
A physician visits an existing patient at their residence to provide care involving a low level of medical decision making. The visit lasts at least 30 minutes.
215 $58 $116
Initial nursing facility care, high complexity
An initial visit by a healthcare provider to a patient in a nursing facility involving a high level of medical decision making, lasting at least 45 minutes.
181 $145 $240
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
53 $61 $97
Home health plan of care certification
Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians.
44 $44 $80
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
43 $72 $220
Home visit, new patient, moderate complexity
A home visit for a new patient involving moderate medical decision making, lasting at least 60 minutes.
39 $114 $250
Home health agency supervision, complex multidisciplinary care
Supervision by a physician or allowed practitioner for a patient receiving Medicare-covered services from a participating home health agency. This involves complex and multidisciplinary care modalities, with the patient not present during the supervision.
29 $89 $200
Annual depression screening 18 $21 $30
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
17 $97 $250
Nursing facility visit, high complexity
A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves a high level of medical decision making and takes at least 45 minutes.
14 $121 $179
Nursing facility visit, moderate complexity
A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves moderate medical decision making and takes at least 30 minutes.
12 $83 $121
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$5,575
Total received (2018-2024)
Avg $796/year across 7 years
Top 7% in CA for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
43
Companies
196
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,575 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,106
2023
$1,466
2022
$933
2021
$693
2020
$370
2019
$630
2018
$376

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ACADIA Pharmaceuticals Inc
$299
SK Life Science, Inc.
$187
Otsuka America Pharmaceutical, Inc.
$150
Teva Pharmaceuticals USA, Inc.
$122
Lilly USA, LLC
$53
Radius Health, Inc.
$43
Lundbeck LLC
$40
PFIZER INC.
$37
Indivior Inc.
$28
AstraZeneca Pharmaceuticals LP
$26
Eisai Inc.
$25
Mylan Specialty L.P.
$25
Sumitomo Pharma America, Inc.
$20
Corcept Therapeutics
$20
SCILEX PHARMACEUTICALS INC.
$19
Vanda Pharmaceuticals Inc.
$13
Top 3 companies account for 57.5% of 2024 payments
All-time payments by company (2018-2024) ›
ACADIA Pharmaceuticals Inc
$1,113
Avanir Pharmaceuticals, Inc.
$453
CMP Pharma, Inc.
$398
SK Life Science, Inc.
$373
Astellas Pharma US Inc
$346
Teva Pharmaceuticals USA, Inc.
$318
Otsuka America Pharmaceutical, Inc.
$279
Neurocrine Biosciences, Inc.
$271
Novartis Pharmaceuticals Corporation
$179
Sunovion Pharmaceuticals Inc.
$168
Lilly USA, LLC
$166
Medtronic, Inc.
$160
Alkermes, Inc.
$125
Bayer HealthCare Pharmaceuticals Inc.
$123
Janssen Pharmaceuticals, Inc
$99
GlaxoSmithKline, LLC.
$75
PFIZER INC.
$68
Lundbeck LLC
$65
Inari Medical, Inc.
$62
Novo Nordisk Inc
$61
AstraZeneca Pharmaceuticals LP
$60
Eisai Inc.
$56
Merck Sharp & Dohme Corporation
$53
SUN PHARMACEUTICAL INDUSTRIES INC.
$43
Radius Health, Inc.
$43
Vanda Pharmaceuticals Inc.
$42
Amarin Pharma Inc.
$35
Sumitomo Pharma America, Inc.
$34
Biogen, Inc.
$31
Indivior Inc.
$28
Mylan Specialty L.P.
$25
Takeda Pharmaceuticals U.S.A., Inc.
$24
Scilex Pharmaceuticals Inc.
$22
Allergan, Inc.
$21
ABBVIE INC.
$21
UROVANT SCIENCES INC
$20
Corcept Therapeutics
$20
Hologic, LLC
$19
SCILEX PHARMACEUTICALS INC.
$19
Boehringer Ingelheim Pharmaceuticals, Inc.
$18
Merck Sharp & Dohme LLC
$16
Ultragenyx Pharmaceutical Inc.
$15
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$11
Top 3 companies account for 35.2% of all-time payments
Associated products mentioned in payments ›
ABRE · ADUHELM · AIRSUPRA · AMYVID · ANORO · ANORO ELLIPTA · APTIOM · AREXVY · ARISTADA · AUSTEDO · Austedo XR · BAQSIMI · BELSOMRA · BREZTRI · CaroSpir · Carospir · Dayvigo · ELIQUIS · ENTRESTO · FANAPT · FARXIGA · FLOWTRIEVER CATHETER · FORTEO · Fanapt · GEMTESA · INGREZZA · INVOKANA · JANUVIA · JARDIANCE · KAPSPARGO · Kerendia · Korlym · LATUDA · LEQVIO · Leqembi · MOUNJARO · MYRBETRIQ · NUEDEXTA · NUPLAZID · NURTEC ODT · Norliqva · Nuedexta · Ongentys · Ozempic · PERSERIS · REXULTI · RYBELSUS · Rybelsus · S · STEGLATRO · THINPREP 2000 PROCESSOR · TRADJENTA · TRELEGY ELLIPTA · TRULICITY · Tymlos · UBRELVY · UZEDY · Uloric · VESICARE · VRAYLAR · Vascepa · XARELTO · XIFAXAN · YUPELRI · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 7% for family medicine in CA.

Looking for a family medicine specialist in Tustin?
Compare family medicine physicians in the Tustin area by procedure volume, costs, and industry payment transparency.
Browse family medicine physicians nearby

Geographic Context

Family medicine physicians within 10 mi
2,439
Per 100K population
77.1
County median income
$113,702
Nearest hospital
FOOTHILL REGIONAL MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Schreiman is a mixed practice specialist, with above-average Medicare volume (top 11% in CA), with low-engagement industry engagement in the top 7% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Schreiman experienced with home visit, established patient, moderate complexity?
Based on Medicare claims data, Dr. Schreiman performed 980 home visit, established patient, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Schreiman receive payments from pharmaceutical companies?
Yes. Dr. Schreiman received a total of $5,575 from 43 companies across 196 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Schreiman's costs compare to other family medicine physicians in Tustin?
Dr. Schreiman's average Medicare payment per service is $92. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Schreiman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →